BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23995611)

  • 1. Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies.
    Frassanito MA; Rao L; Moschetta M; Ria R; Di Marzo L; De Luisi A; Racanelli V; Catacchio I; Berardi S; Basile A; Menu E; Ruggieri S; Nico B; Ribatti D; Fumarulo R; Dammacco F; Vanderkerken K; Vacca A
    Leukemia; 2014 Apr; 28(4):904-16. PubMed ID: 23995611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients.
    Frassanito MA; De Veirman K; Desantis V; Di Marzo L; Vergara D; Ruggieri S; Annese T; Nico B; Menu E; Catacchio I; Ria R; Racanelli V; Maffia M; Angelucci E; Derudas D; Fumarulo R; Dammacco F; Ribatti D; Vanderkerken K; Vacca A
    Leukemia; 2016 Mar; 30(3):640-8. PubMed ID: 26487273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma.
    Desantis V; Frassanito MA; Tamma R; Saltarella I; Di Marzo L; Lamanuzzi A; Solimando AG; Ruggieri S; Annese T; Nico B; Vacca A; Ribatti D
    Ann Hematol; 2018 Jul; 97(7):1251-1258. PubMed ID: 29589107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
    Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX
    J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
    Xu S; Menu E; De Becker A; Van Camp B; Vanderkerken K; Van Riet I
    Stem Cells; 2012 Feb; 30(2):266-79. PubMed ID: 22102554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia.
    Pan C; Liu P; Ma D; Zhang S; Ni M; Fang Q; Wang J
    Biomed Pharmacother; 2020 Oct; 130():110610. PubMed ID: 34321159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model.
    Menu E; Asosingh K; Indraccolo S; De Raeve H; Van Riet I; Van Valckenborgh E; Vande Broek I; Fujii N; Tamamura H; Van Camp B; Vanderkerken K
    Haematologica; 2006 May; 91(5):605-12. PubMed ID: 16627256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
    Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
    Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
    J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
    Peng Y; Li Z; Li Z
    Biochem Biophys Res Commun; 2013 Nov; 440(4):558-63. PubMed ID: 24113381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.
    Zhou B; Chen WL; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS
    J Oral Pathol Med; 2014 Sep; 43(8):585-92. PubMed ID: 24645915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer.
    Zhu X; Han S; Wu S; Bai Y; Zhang N; Wei L
    Exp Cell Res; 2019 Feb; 375(2):41-50. PubMed ID: 30611739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma.
    De Luisi A; Ferrucci A; Coluccia AM; Ria R; Moschetta M; de Luca E; Pieroni L; Maffia M; Urbani A; Di Pietro G; Guarini A; Ranieri G; Ditonno P; Berardi S; Caivano A; Basile A; Cascavilla N; Capalbo S; Quarta G; Dammacco F; Ribatti D; Vacca A
    Clin Cancer Res; 2011 Apr; 17(7):1935-46. PubMed ID: 21307145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts in digestive tumors.
    Huang L; Xu AM; Liu S; Liu W; Li TJ
    World J Gastroenterol; 2014 Dec; 20(47):17804-18. PubMed ID: 25548479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1.
    Mirandola L; Apicella L; Colombo M; Yu Y; Berta DG; Platonova N; Lazzari E; Lancellotti M; Bulfamante G; Cobos E; Chiriva-Internati M; Chiaramonte R
    Leukemia; 2013 Jul; 27(7):1558-66. PubMed ID: 23354012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironment.
    McDonald LT; Russell DL; Kelly RR; Xiong Y; Motamarry A; Patel RK; Jones JA; Watson PM; Turner DP; Watson DK; Soloff AC; Findlay VJ; LaRue AC
    Neoplasia; 2015 May; 17(5):434-48. PubMed ID: 26025666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1.
    Sanz-Rodríguez F; Hidalgo A; Teixidó J
    Blood; 2001 Jan; 97(2):346-51. PubMed ID: 11154207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
    Basile A; Moschetta M; Ditonno P; Ria R; Marech I; De Luisi A; Berardi S; Frassanito MA; Angelucci E; Derudas D; Specchia G; Curci P; Pavone V; Rossini B; Ribatti D; Bottazzi B; Mantovani A; Presta M; Dammacco F; Vacca A
    J Pathol; 2013 Jan; 229(1):87-98. PubMed ID: 22847671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic.
    Al-Rakan MA; Colak D; Hendrayani SF; Al-Bakheet A; Al-Mohanna FH; Kaya N; Al-Malik O; Aboussekhra A
    J Pathol; 2013 Dec; 231(4):457-65. PubMed ID: 24009142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor α induces myofibroblast differentiation in human tongue cancer and promotes invasiveness and angiogenesis via secretion of stromal cell-derived factor-1.
    Zhou B; Zhuang XM; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS; Chen WL
    Oral Oncol; 2015 Dec; 51(12):1095-102. PubMed ID: 26454580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.